OGEN short interest
Oragenics Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 841,634 |
|---|---|
| Change vs prior report | 35,092 (+4.3%) |
| Change over six months | +16.8% |
| Days to cover | 24.89 (sector: 3.78) |
| Average daily volume | 33,814 |
| Rank in Healthcare | not ranked (OTC, fund or thinly traded) |
OGEN short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 841,634 | +4.3% | 24.89 | 33,814 |
| 2026-09-15 | 806,542 | +1.5% | 36.98 | 21,810 |
| 2026-08-31 | 794,915 | +0.8% | 15.11 | 52,605 |
| 2026-08-14 | 788,923 | +1.0% | 39.10 | 20,177 |
| 2026-07-31 | 781,094 | -0.3% | 31.26 | 24,984 |
| 2026-07-15 | 783,091 | +1.0% | 28.67 | 27,313 |
| 2026-06-30 | 775,021 | +3.0% | 16.84 | 46,036 |
| 2026-06-15 | 752,810 | +6.2% | 13.03 | 57,790 |
| 2026-05-29 | 708,926 | +8.0% | 16.72 | 42,399 |
| 2026-05-15 | 656,580 | -4.0% | 11.78 | 55,742 |
| 2026-04-30 | 683,948 | -2.8% | 11.06 | 61,819 |
| 2026-04-15 | 703,470 | -2.3% | 12.20 | 57,661 |
| 2026-03-31 | 720,353 | -9.1% | 5.52 | 130,490 |
| 2026-03-13 | 792,779 | +39.0% | 1.79 | 442,572 |
| 2026-02-27 | 570,220 | +24.3% | 1.00 | 844,062 |
| 2026-02-13 | 458,764 | -12.5% | 5.70 | 80,461 |
| 2026-01-30 | 524,157 | +806.2% | 1.00 | 1,798,797 |
| 2026-01-15 | 57,838 | -46.5% | 1.68 | 34,528 |
| 2025-12-31 | 108,196 | -22.3% | 1.53 | 70,912 |
| 2025-12-15 | 139,273 | +303.6% | 1.22 | 114,186 |
| 2025-11-28 | 34,508 | -39.5% | 1.00 | 65,551 |
| 2025-11-14 | 57,082 | +60.1% | 1.58 | 36,132 |
| 2025-10-31 | 35,642 | -61.6% | 1.00 | 67,011 |
| 2025-10-15 | 92,847 | +6.8% | 1.00 | 330,265 |
| 2025-09-30 | 86,968 | -25.9% | 1.00 | 143,344 |
import finzdata as yf
yf.Ticker("OGEN").short_interest # every report since 2017
yf.Client().short_interest(["OGEN"], start="2018-01-01")Healthcare short interest · OGEN price history · Who owns OGEN · All short interest